Cargando…
Advances in Promoting the Efficacy of Chimeric Antigen Receptor T Cells in the Treatment of Hepatocellular Carcinoma
SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is one of the most common and deadly cancers worldwide. Its insidious onset, rapid disease progression, and poor prognosis make it difficult to treat. Chimeric antigen receptor (CAR)-T cell therapy, a popular treatment in recent years, has demonstrated...
Autores principales: | Shen, Jie, Yang, Dashuai, Ding, Youming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599749/ https://www.ncbi.nlm.nih.gov/pubmed/36291802 http://dx.doi.org/10.3390/cancers14205018 |
Ejemplares similares
-
Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma
por: Tseng, Hsiang-chi, et al.
Publicado: (2020) -
Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma
por: Dai, Kai, et al.
Publicado: (2021) -
A Practical Nomogram and Risk Stratification System Predicting the Cancer-Specific Survival for Patients With Advanced Hepatocellular Carcinoma
por: Yang, Dashuai, et al.
Publicado: (2022) -
Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy
por: Zhang, Ren-Yu, et al.
Publicado: (2019) -
Chimeric Antigen Receptor Design and Efficacy in Ovarian Cancer Treatment
por: Terlikowska, Katarzyna M., et al.
Publicado: (2021)